ACADIA Pharmaceuticals
ACAD
#3646
Rank
C$3.79 B
Marketcap
$22.78
Share price
-2.44%
Change (1 day)
-7.28%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): C$0.36 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$0.95 Billion. , an increase over its 2023 earnings that were of -C$71.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 C$0.36 B-605.67%
2023 -C$71.69 Million-76.09%
2022 -C$0.3 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.4 Billion19.88%
2019 -C$0.33 Billion-3.92%
2018 -C$0.35 Billion-15.04%
2017 -C$0.41 Billion6.33%
2016 -C$0.38 Billion64.55%
2015 -C$0.24 Billion77.47%
2014 -C$0.13 Billion143.69%
2013 -C$53.31 Million81.93%
2012 -C$29.3 Million-8.73%
2011 -C$32.1 Million-251.39%
2010 C$21.2 M-133.2%
2009 -C$63.87 Million-30.82%
2008 -C$92.32 Million6.43%
2007 -C$86.75 Million25.89%
2006 -C$68.91 Million36.99%
2005 -C$50.3 Million37.22%
2004 -C$36.66 Million19.96%
2003 -C$30.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$57.12 Million-115.76%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.60 B 4,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.81 B 4,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.49 B 6,658.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.77 Billion-3,346.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$54.26 Million-114.97%๐Ÿ‡บ๐Ÿ‡ธ USA